$SLS.d
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, i...
$5,372.98
$11.53
4
$349.00
SELLAS Life Sciences Group, Inc. Common Stock Metrics
Metric
Show % of Total
Market Cap by Network
Key Facts
Type
Fees
Fees
Market Data
Active Addresses
Transfer Count
Transfer Volume
Tokens
Primary Market
Investment
Fees
Fees
Service Providers
Custodian
Legal Identifier
Legal & Regulatory
U.S. Securities Act Reg. S Exemption
SEC - U.S. Securities and Exchange Commission
Segregation
Remote
Insurance
Fees
Fees
Fees
Fees
Fees
Holders
View detailed token
holder breakdowns
Sign up for a free account to get access to breakdowns of which investor addresses hold an RWA across blockchain networks.
RWA.xyzAll Rights Reserved